Table 1 Prescreening of candidate variants (step 1) and ranking of known pathogenic variants (step 2)
Step 1 | Step 2 | ||||||
---|---|---|---|---|---|---|---|
Patient | Gene | Disease | MinHDR | Conclusion | m | Rank | P-value |
105 | SUCLA2 | MC | 0.56 | Suitable | 60 | 2 | 0.038 |
250 | QRSL1 | LIMD | 0.62 | Suitable | 74 | 1 | 0.038 |
268 | BOLA3 | LIMD | 0.75 | Suitable | 88 | 4 | 0.019 |
276 | MRPS23 | HD | 0.62 | Suitable | 59 | 2 | 0.038 |
286 | BOLA3 | LD | 0.64 | Suitable | 69 | 2 | 0.019 |
314 | BOLA3 | CM | 0.60 | Suitable | 69 | 2 | 0.038 |
330 | NDUFAF6 | MC | 0.33 | Inconclusive | — | — | — |
559 | TUFM | NLIMD | 0.36 | Inconclusive | — | — | — |